| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |